Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-23-002201

CEO and President sold 91,868 shares at $0.88 ($80,614)

From the SEC's structured data for this filing

Trades in this filing

Butler John P. · CEO and President

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-01 Sale : show line 1 in the form −38,259 $0.88 $33,572 1,622,481 D
2023-03-01 Sale : show line 2 in the form −47,239 $0.88 $41,452 1,575,242 D
2023-03-01 Sale : show line 3 in the form −6,370 $0.88 $5,590 1,568,872 D
Open-market sales · 91,868 sh · avg $0.88 · $80,614
Loading xslF345X03/primarydocument.xml…